Page 21 - I. Chemical biology and drug discovery
P. 21

Synthesis and biological evaluation of gramistilbenoids and vinyl-stilbene series

  Dipesh S. Harmalkar, Sreenivasulu Godesi, DongIk Kwak, and Kyeong Lee*
  College of Pharmacy, Dongguk University-Seoul, Goyang, Republic of Korea ,10326
                                             INTRODUCTION


  •    Norovirus (NV), is the most common cause of acute gastroenteritis worldwide which causes approximately 200,000 deaths annually and estimated to cost
       $60 billion worldwide due to healthcare costs and lost productivity. To date, there have been no specific drugs or vaccines to treat NV infections; thus, there
       is a pressing need to develop effective anti-NV therapeutics.
  •    We evaluated the inhibitory effect of natural stilbenes, Gramistilbenoids A-C (isolated from Arundina Graminifolia) and different stilbene-based analogs on
       RNA genome replication of human NV (HNV) using a virus replicon-bearing cell line (HG23) which led to the identification of a hit containing stilbene
       scaffold 5.
  •    Compound 18k demonstrated an excellent safety profile, the highest suppressive effect, and was selective for HNV replication via a viral RNA polymerase-
       independent manner. Its potential host-targeting antiviral mechanism was further supported by specific activation of heat shock factor 1-dependent stress-
       inducible pathway by 18k. These results suggest that 18k might be a promising lead compound for developing novel NV inhibitors with the novel antiviral
       mechanism.









                                          RESULTS & DISCUSSION

  Table 1. Dose-dependent Response  of Compounds 16c, 18e, 18f, and 18k a  A
           Dose-dependent response o              Does-
             n cell viability and NV  Therapeutic  dependent
                  replication                   response on
    Comp                              index     viral protein
                                    CC /EC
           CC (µM)     EC (µM)        50   50   expression
              50
                         50
                                                EC 50 (µM)
     16c      > 10        4.4         > 2.2        8.0
     18e     > 100        2.0         > 50        0.71
                                                             B
     18f     > 100       1.44         > 69        1.97

     18k     > 100       2.43        > 41.2        0.8

   2CMC b     12.2        4.0          3.1         4.8
  Table 2 . Liver Microsomal Stability Assay a                  Fig. 1. Dose-dependent effects of 18e, 18f, and

                          Metabolic Stability Assay             18k on (A) HNV replication; (B) HNV viral
                                                                protein expression   B
                                                                    A                                C
                    Human (%)             Mouse (%)
     Comp
               (+) NADP              (+) NADP
                         (-) NADPH              (-) NADPH
                  H                     H
                                                             Fig. 2. (A) Effects of the representative compounds 18e, 18f,
      18e        20.0       92.1       67.7       88.4       and 18k on HNV RdRp activity at 10 µM. PPNDS was used as
                                                             a positive control; (B) Dose-dependent effects of 18k on MNV-
      18f        44.1       > 100      38.3       83.1       1 and (C) Dose-dependent effects of 18k on FCV infections.

      18k        89.1       94.3       70.5       99.2                    ACKNOWLEDGEMENTS

   Verapamil     13.6        -           -          -                     This work was supported by the National
                                                                          Research Foundation of Korea (NRF), grant
    CONCLUSION                              REFERENCES                    funded by the Korea government (MSIT). (No.
                                                                          2018R1A5A2023127 and
   •  An additional series of structurally-diverse stilben                2016R1D1A1B03933100).
      oids was synthesized and evaluated based on the h •  D. S. Harmalkar; Q. Lu; K. Lee; J.
      it compound 5, resulting in the identification of no  Nat. Prod. 2018, 81, 798-805.  Contact information
      vel NV inhibitors that inhibited NV replication in  •  D. S. Harmalkar; S. J. Lee; Q. Lu; M.
      the very low μM or sub-μM range.      I. Kim; J. Park; H. Lee; M. Park; A.
                                            Lee; C. Lee; K. Lee; Eur. J. Med.
   •  Compounds 18e, 18f, and 18k exhibited excellent   Chem. 184 (2019) 111753.
      anti-NV activity with TIs in the range of 40 to 70.
   16   17   18   19   20   21   22   23   24   25   26